Oligoclonality of serum immunoglobulin G antibody responses to Streptococcus pneumoniae capsular polysaccharide serotypes 6B, 14, and 23F

Infection and Immunity

Volumn 65, Issue 12, 1997, Pages 5103-5109

  Lucas, Alexander H ^a   Granoff, Dan M ^a,b   Mandrell, Robert E ^a,d   Connolly, Charles C ^a   Shan, Asra S ^c   Powers, Douglas C ^a,e  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d WESTERN REGIONAL RESEARCH CENTER   (United States)

^e EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; MONOCLONAL ANTIBODY; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE; POLYCLONAL ANTIBODY;

ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BACTERIAL MEMBRANE; BACTERIUM IDENTIFICATION; GENE EXPRESSION; HUMAN; HUMAN EXPERIMENT; IMMUNOGLOBULIN BLOOD LEVEL; INTRAMUSCULAR DRUG ADMINISTRATION; ISOELECTRIC FOCUSING; NORMAL HUMAN; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; VACCINATION;

EID: 0030729224     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.12.5103-5109.1997     Document Type: Article

References (66)

1. Akolkar, P. N., S. K. Sikder, S. B. Bhattacharya, J. Liao, F. Gruezo, S. L. Morrison, and E. A. Kabat. 1987. Different VL and VH germ-line genes are used to produce similar combining sites with specificity for α(1→6)dextrans. J. Immunol. 138:4472-4479.
2. Alonsode Velasco, E., A. F. M. Verheul, J. Verhoef, and H. Snippe. Streptococcus pneumoniae: virulence factors, pathngenesis, and vaccines. Microhiol. Rev. 59:591-603.
3. Amir, J., X. Liang, and D. M. Granoff. 1990. Variability in the functional activity of vaccine-induced antibody to Haemophilus influenzae type b. Pediatr. Res. 27:358-364.
4. Anderson, E. L., D. J. Kennedy, K. M. Geldmacher, J. Donnelly, and P. M. Menddman. 1996. Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants. J. Pediatr. 128:649-653.
5. Atkinson, M. J., M. J. Cowan, and A. J. Feeney. 1996. New alleles of IGKV genes A2 and A18 suggest significant human IGKV locus polymorphisms. Immunogenetics 44:115-120.
6. Augustin, A., and H. Cosenza. 1976. Expression of new idiotypes following neonatal idiotypic suppression of a dominant clone. Eur. J. Immunol. 6:497-501.
7. Austrian, R. 1981. Pneumococcus: the first one hundred years. Rev. Infect. Dis. 3:183-189.
8. Austrian, R. 1984. Pneumococcal infections, p. 257-288. In R. Germanier (ed.), Bacterial vaccines. Academic Press, Inc., Orlando, Fla.
9. Barington, T., L. Hougs, L. Juul, H. O. Madsen, L. P. Ruder, C. Heilmann, and A, Svejgaard. 1996. The progeny of a single virgin B cell predominates the human recall B cell response to the capsular polysaccharide of Haemophilus influenzae type b. J. Immunol. 157:4016-4027.
10. Bona, C. 1993. Molecular characteristics of anti-polysaccharidc antibodies. Springer Semin. Immunopathol. 15:103-118.
11. Borgoño, J. M., A. A. McLean, P. P. Vella, A. F. Woodhour, I. Canepa, W. L. Davidson, and M. R. Hilleman. 1978. Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants. Proc. Soc. Exp. Biol. Med. 157:148-154.
12. Bruyn, G. A. W., B. J. M. Zegers, and R. van Furth. 1992. Mechanisms of host defense against infection with Streptococcus pneumoniae. Clin. Infect. Dis. 14:251-262.
13. Butler, J. C., R. F. Breiman, J. F. Campbell, H. B. Lipman, C. V. Broome, and R. R. Facklam. 1993. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA 270:1826-1831.
14. Carroll, W. L., E. E. Adderson, A. H. Lucas, G. J. Silverman, R. A. Insel, M. G. Scott, M. H. Nahm, and P. G. Shackelford. 1994. Molecular basis of antibody diversity, p. 207-209. In R. W. Ellis and D. M. Granoff (ed.), Development and clinical uses of Haemophilus b conjugate vaccines. Marcel Dekker, Inc., New York, N.Y.
15. Chen, C., U. Bruderer, and M. B. Rittenberg. 1992. The developmental patterns of B cell precursors distinguishing between environmental and non-environmental forms of phosphocholine. Cell. Immunol. 143:378-388.
16. Claflin, J. L., and S. Rudikoff. 1977. Uniformity in a clonal repertoire: a case for a germ-line basis of antibody diversity. Cold Spring Harbor Symp. Quant. Biol. 41:725-734.
17. Ellis, R. W., and D. M. Granoff (ed.). 1994. Development and clinical uses of Haemophilus b conjugate vaccines. Marcel Dekker, Inc., New York, N.Y.
18. Emara, M. G., N. L. Tout, A. Kaushik, and J. S. Lam. 1995. Diverse VH and Vκ genes encode antibodies to Pseudomonas aeruginosa LPS. J. Immunol. 155:3912-3921.
19. Geckler, W., B. Blomberg, C. dePreval, and M. Cohn. 1977. On the genetic dissection of a specific humoral response to α(1→3) dextran. Cold Spring Harbor Symp. Quant. Biol. 41:743-748.
20. Granoff, D. M., P. G. Shackelford, S. J. Holmes, The Collaborative Study Group, and A. H. Lucas. 1993. Variable region expression in the antibody responses of infants vaccinated with Haemophilus influenzae type b polysaccharide-protein conjugates: description of a new λ light chain-associated idiotype and the relation between idiotype expression, avidity, and vaccine formulation. J. Clin. Invest. 91:788-796.
21. Granoff, D. M., and A. H. Lucas. 1995. Laboratory correlates of protection against Haemophilus influenzae type b disease: importance of assessment of antibody avidity and immunologic memory. Ann. N. Y. Acad. Sci. 754:278-288.
22. Hansburg, D., D. E. Briles, and J. M. Davie. 1976. Analysis of the diversity of murine antibodies to dextran B1355. I. Generation of a large, pauciclonal response by a bacterial vaccine. J. Immunol. 117:569-575.
23. Heidelberger, M., C. M. MacLeod, and M. M. diLappi. 1948. The human antibody response to simultaneous injection of six specific polysaccharides of pneumococcus. J. Exp. Med. 88:369-372.
24. Insel, R. A., and P. W. Anderson. 1986. Oligosaccharide-protein conjugate vaccines induce and prime for oligoclonal IgG antibody responses to the H. inftuenzae b capsular polysaccharide in human infants. J. Exp. Med. 163:262-269.
25. Insel, R. A., A. Kittelberger, and P. Anderson. 1985. Isoelectric focusing of human antibody to the Haemophilia influenzae b capsular polysaccharide: restricted and identical spectrotypes in adults. J. Immunol. 135:2810-2816.
26. Käyhty, H., H. Åhman, P.-R. Rönnberg, R. Tillikainen, and J. Eskola. 1995. Pneumococcal polysaccharidc-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. J. Infect. Dis. 172:1273-1278.
27. Käyhty, H., and J. Eskola. 1996. New vaccines for the prevention of pneumococcal infections. Emerg. Infect. Dis. 2:289-298.
28. Kenne, L., B. Lindberg, and J. K. Madden. 1979. Structural studies of the capsular antigen from Streptococcus pneumoniae type 26. Carbohydr. Res. 73:175-182.
29. Konradsen, H. B., M. Hahn-Zoric, and L. Å. Hanson. 1994. Differences within mono- and dizygotic twin-pairs in spectrotypes and clones of IgG2 antibodies to pneumococcal polysaccharide type-1 and C-polysaccharide after vaccination. Scand. J. Immunol. 40:423-428.
30. Lindberg, B., J. Lonngren, and D. A. Powell. 1977. Structural studies on the specific type-14 pneumococcal polysaccharide. Carbohydr. Res. 58:177-186.
31. Lucas, A. H. 1996. Genetic basis and somatic evolution of a human polysaccharide-specific antibody repertoire, p. 121-143. In M. Zouali (ed.), Human B cell superantigens. R. G. Landes Co., Austin, Tex.
32. Lucas, A. H., F. H. Azmi, C. M. Mink, and D. M. Granoff. 1993. Age-dependent V region expression in the human antibody response to the Haemophilus influenzae type b polysaccharide. J. Immunol. 150:2056-2061.
33. Lucas, A. H., and D. M. Granoff. 1995. Functional differences in idiotypically defined IgG1 anti-polysaccharide antibodies elicited by vaccination with Haemophilus influenzae type b polysaccharide-protein conjugates. J. Immunol. 154:4195-4202.
34. Lucas, A. H., R. J. Langley, D. M. Granoff, M. H. Nahm, M. Y. Kitamura, and M. G. Scott. 1991. An idiotypic marker associated with a germ-line encoded kappa light chain variable region that predominates the vaccine-induced human antibody response to the Haemophilus influenzae b polysaccharide. J. Clin. Invest. 88:1811-1818.
35. Lucas, A. H., J. W. Larrick, and D. C. Reason. 1994. Variable region sequences of a protective human monoclonal antibody specific for the Haemophilus influenzae type b capsular polysaccharide. Infect. Immun. 62:3873-3880.
36. Lue, C., A. J. Tarkowski, and J. Mistecky. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies. J. Immunol. 140:3793-3800.
37. Morrow, C. D., E. M. Macy, and R. H. Stevens. 1981. Analysis of human anti-diphtheria antibodies by isolelectric focusing: evidence for restricted clonal heterogeneity of anti-fragment A antibodies. Infect. Immun. 31:1132-1137.
38. Makherjee, J., G. Nussbaum, M. D. Scharff, and A. Casadevall. 1995. Protective and nonprotective monoclonal antibodies to Cryptococcus neoformans originating from one B cell. J. Exp. Med. 181:405-409.
39. Musher, D. M., J. E. Groover, D. A. Watson, J. P. Pandey, M. C. RodriguezBarradas, R. E. Baughn, M. S. Pollack, E. A. Graviss, M. de Andrade, and C. I. Amos. 1997. Genetic regulation of the capacity to make immunoglobulin G to pneumococcal capsular polysaccharides. J. Invest. Med. 45:57-68.
40. Musher, D. M., B. Johnson, Jr., and D. A. Watson. 1990. Quantitative relationship between anticapsular antibody measured by enzyme-linked immunosorbent assay or radioimmunoassay and protection of mice against challenge with Streptococcus pneumoniae serotype 4. Infect. Immun. 58: 3871-3876.
41. Nahm, M. H., K. H. Kim, P. Anderson, S. V. Hetherington, and M. K. Park. 1995. Functional capacities of clonal antibodies to Haemophilus influenzae type b polysaccharide. Infect. Immun. 63:2989-2994.
42. Nahm, M. H., G. R. Siber, and J. V. Olander. 1996. A modified Farr assay is more specific than ELISA for measuring antibodies to Streptococcus pneumoniae capsular polysaccharides. J. Infect. Dis. 173:113-118.
43. Pargent, W., K. F. Schäble, and H. G. Zachau. 1991. Polymorphism and haplotypes in the human immunoglobulin locus. Eur. J. Immunol. 21:1829-1835.
44. Park, M. K., Y. Sun, J. V. Olander, J. W. Hoffmann, and M. H. Nahm. 1996. The repertoire of human antibodies to the carbohydrate capsule of Streptococcus pneumoniae 6B. J. Infect. Dis. 174:75-82.
45. Powers, D. C., E. L. Anderson, K. Lottenbach, and C. M. Mink. 1996. Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults. J. Infect. Dis. 173:1014-1018.
46. 10) terpolymer and bacterial levan in κ-deficient mice. Eur. J. Immunol. 25:1039-1043.
47. Quataert, S. A., C. S. Kirch, L. J. Q. Wiedl, D. C. Phipps, S. Strohmeyer, C. O. Cimino, J. Skuse, and D. V. Madore. 1995. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S. Clin. Diagn. Lab. Immunol. 2:590-597.
48. Reason, D. C., and A. H. Lucas. 1997. Functional expression of the IGKV A18b gene and its idiotypic cross-reactivity with the A2 variable region. Immunogenetics 45:343-344.
49. Rebers, P. A., and M. Heidelberger. 1961. The specific polysaccharide of type VI pneamococcus. II. The repeating unit. J. Am. Chem. Soc. 83:3056-3059.
50. Reisen, W. F., F. Skvaril, and D. G. Braun. 1976. Natural infection of man with group A streptococci. Levels, restriction in class, subclass and type, and clonal appearance of polysaccharide-group-specific antibodies. Scand. J. Immunol. 5:383-390.
51. Richards, J. C., and M. B. Perry. 1987. Structure of the specific capsular polysaccharide of Streptococcus pneumoniae type 23F (American type 23). Biochem. Cell Biol. 66:758-771.
52. Robbins, J. B., R. Austrian, C.-J. Lee, S. C. Rastogi, G. Schiffman, J. Henrichsen, P. H. Mäkela, C. V. Broome, R. R. Facklam, R. H. Tiesjema, and J. C. Parke, Jr. 1983. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J. Infect. Dis. 148:1136-1159.
53. Rosén, A., K. Ek, and P. Aman. 1979. Agarose isoelectric focusing of native human immunoglobulin M and α2-macroglobulin. J. Immunol. Methods. 28:1-11.
54. Rubinstein, L. J., and K. E. Stein. 1988. Murine immune response to the Neisseria meningitidis group C capsular polysaccharide: specificity. J. Immunol. 141:4357-4362.
55. Sasso, E. H., J. H. Buckner, and L. A. Suzuki. 1995. Ethnic differences in polymorphism of an immunoglobulin VH3 gene. J. Clin. Invest. 96:1591-1600.
56. Schlesinger, Y., D. M. Granoff, and The Collaborative Vaccine Study Group. 1992. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. JAMA 267:1489-1494.
57. Scott, M. G., D. L. Crimmins, D. W. McCourt, G. K. Chung, F. Schable, R. Thiebe, and H. G. Zachau. 1991. Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. IV. The less frequently expressed VL are heterogeneous. J. Immunol. 147:4007-4013.
58. Scott, M. G., J. J. Tarrand, D. L. Crimmins, D. W. McCourt, N. R. Siegel, C. E. Smith, and M. H. Nahm. 1989. Clonal characterization of the human antibody repertoire to Haemophilus influenzae b polysaccharide. II. IgG antibodies contain VH genes from a single VH family and VL genes from at least four VL families. J. Immunol. 143:293-298.
59. Scott, M. G., D. L. Crimmins, D. W. McCourt, I. Zocher, R. Thiebe, H. G. Zachau, and M. H. Nahm. 1989. Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. III. A single VκII gene and one of several J genes are joined by an invariant arginine to form the most common L chain V region. J. Immunol. 143:4110-4116.
60. Sell, S. H., P. F. Wright, W. K. Vaughn, J. Thompson, and G. Schiffman. 1981. Clinical studies of pneumococcal vaccines in infants. I. Reactogenicity and immunogenicity of two polyvalent polysaccharide vaccines. Rev. Infect. Dis. 3:S97-S107.
61. Shackelford, P. G., S. J. Nelson, A. T. Palma, and M. H. Nahm. 1988. Human antibodies to group A streptococcal carbohydrate. Ontogeny, subclass restriction and clonal diversity. J. Immunol. 140:3200-3205.
62. Shaw, D. R., P. Kirkham, H. W. Schroeder, Jr., P. Roben, and G. J. Silverman. 1995. Structure-function studies of human monoclonal antibodies to pneumococcus type 3 polysaccharide. Ann. N. Y. Acad. Sci. 764:370-373.
63. Shelly, M. A., H. Jacoby, G. J. Riley, B. T. Graves, M. Pichichero, and J. J. Treanor. 1997. Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults. Infect. Immun. 65:242-247.
64. Smit, P., D. Oberhlozer, S. Hayden-Smith, H. J. Koornhof, and M. R. Hilleman. 1977. Protective efficacy of pneumococcal polysaccharide vaccines. JAMA 238:2613-2616.
65. Steinhoff, M. C., K. Edwards, H. Keyserling, M. L. Thoms, C. Johnson, D. Madore, and D. Hogerman. 1994. A randomized comparison of three bivalent Streptococcus pneumoniae glycoprotein conjugate vaccines: effect of polysaccharide size and linkage characteristics. Pediatr. Infect. Dis. J. 13: 368-372.
66. Weng, N.-P., L.-Y. Yu-Lee, I. Sanz, B. M. Patten, and D. M. Marcus. 1992. Structure and specificities of anti-ganglioside autoantibodies associated with motor neuropathies. J. Immunol. 149:2518-2529.